



Globally,	 tuberculosis	 (TB)	 remains	 one	 of	 the	 leading	
causes of mortality due to infectious diseases.[1,2] In 2018, a 
total	of	1.5	million	people	died	from	TB	and	eight	countries	
accounted	 for	 two‑thirds	 of	 the	 new	 cases;	 India	was	first	
followed	 by	China,	 Indonesia,	 the	 Philippines,	 Nigeria,	
Bangladesh,	 and	 South	Africa.[2]	Although	TB	 is	 curable	
requiring a daily combination chemotherapy for at least 6 
months, its management is often affected by comorbid or 
other	underlying	factors.	These	factors	contribute	to	the	TB	
burden and range from the presence of other diseases to social 
determinants of health.[3]	The	global	burden	of	TB	remains	
enormous mainly because of poor control in South-Eastern 
Asia,	Sub‑Saharan	Africa,	and	Western	Pacific,	the	emergence	




of treatment challenge as these may decrease compliance and 
increase the probability of depression occurring as comorbidity 
among	TB	patients.[5,6]
Unfortunately,	TB	often	affects	vulnerable	groups	such	as	the	
poor, malnourished, and immuno-compromised, especially 
those	with	HIV/AIDS,	among	whom	it	remains	the	leading	
killer disease.[2]	Nigeria	 has	 a	 high	 prevalence	 of	TB	 and	
ranks 6th	 among	 the	 30	TB	 high‑burden	 countries	 in	 the	
world	 that	 accounted	 for	 up	 to	 87%	of	 the	global	 new	TB	
cases in 2018.[2] Studies have shown that chronic diseases 
such	as	TB,	HIV/AIDS,	diabetes	mellitus,	and	hypertension	
often coexist with psychiatric illnesses such as depression, 
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patients is high. Achieving cure and preventing undesirable treatment outcomes in this region would involve a holistic approach that considers 
the interplay of patient’s behavioral, social, and medical factors.
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oftentimes requiring frequent hospitalizations and posing 
a great challenge to patient care.[7,8] In Nigeria, the effect 
of	 depression	 on	TB	 can	 be	 potentiated	 among	 groups	 of	
people with a vulnerability background of poverty, depressed 
immunity, diseases that require chronic management as well 
as other health determinants.
The prevalence of depression and anxiety disorders among 
patients	with	TB	 is	 estimated	 to	 range	 between	 40%	 and	
70%.[7] Studies carried out in different parts of the world on 
the	 prevalence	of	 depression	 among	TB	patients	 showed	 a	
lower prevalence (26.3%) in India;[9] a comparable proportion 
in Nigeria (45.5%)[8] and Ethiopia (51.9%);[5] and a higher 
prevalence	 rate	 of	 80%	 in	Pakistan.[10] Although the actual 
cause of the depression occurring as comorbidity remains 
unclear, the presence of chronic unexplainable pain, frequent 
hospital admissions, hospital dependency, stigmatization, drug 
resistance and chronic drug use are believed to be some of the 
factors associated.[3,5,6]
This study sought to determine the prevalence and determinants 
of	depression	among	TB	patients	in	hospitals	in	Kano.	Findings	
from this study will be useful for health-care providers in 










general curative medical services, as well as serving as a 
referral	 center	 for	 various	peripheral	 hospitals	within	Kano	
and its neighboring states. The hospital has 500 beds capacity 
with	various	clinical	departments.	The	DOTS	clinic	of	AKTH	
commenced in June 2007, and it serves as a tertiary referral center 
for patients from Tarauni and surrounding local government 
areas (districts). Activities in the clinic are coordinated by 2 
consultants	(Health	Specialist),	1	nurse,	3	Community	Health	
Extension	Workers	(CHEWs),	record	staff,	pharmacist,	acid‑fast	
bacilli microscopist, and laboratory assistants. Complicated 
cases are referred to the Respiratory Unit of the teaching hospital.
MMSH,	 Kano	 is	 a	 secondary	 health	 facility	 that	 was	
established	in	1926	in	the	core	Kano	city	and	is	one	of	 the	
oldest and largest hospitals in Nigeria. The hospital became a 
specialist hospital in the year 1997. The hospital is enclosed 
within	the	walls	of	old	Kano	city.	It	is	about	200	meters	away	
from	the	Kofar	Mata	gate	to	the	east	and	about	500	m	to	the	
west of Emir’s palace. The hospital serves both the people 
within	Kano	and	those	from	neighboring	states	such	as	Jigawa,	
Katsina,	and	Zamfara,	among	others.	It	also	receives	patients	
from neighboring countries such as Niger and Mali republics. 
It has 20 departments and a bed capacity of about 250. The 
DOTS clinic of the hospital is located within the hospital close 
to	the	accident	and	emergency	unit,	and	an	average	of	25	TB	
patients	are	seen	daily.	Patients	that	require	special	attention,	
for example, those with adverse drug reactions, are referred 
to the pulmonology unit of the hospital.
IDH	 is	 also	 a	 secondary	 health	 facility	 designated	 by	 the	
state government to treat and manage infectious diseases. 
The	 hospital	 is	 located	 in	 Fagge	Local	Government	 area	
along France road about 300 m from Fagge central mosque. 
The hospital receives patients from Northern Nigeria and 
neighboring countries such as Niger and Cameroon. It serves 
as	a	referral	center	in	the	management	of	TB	and	HIV/AIDS	
patients.	All	TB	 and	HIV/AIDS‑related	medical	 care	 are	
provided free of charge to the patients. The hospital has a 
chest clinic that runs every day and receives an average of 




The	 study	 population	 comprised	TB	 patients	who	were	
10 years old and above and attending the DOTS clinic in 
AKTH,	MMSH,	and	IDH.	Patients	who	were	enrolled	in	the	
DOTS clinic of any of the three hospitals had commenced anti 
TB	medications	for	at	least	2	weeks,	were	not	acutely	ill,	and	
assented or consented to participate were included in the study.
Study design and methods
The study was a cross-sectional descriptive study. A sample 
size	of	308	was	estimated	using	the	following:	95%	confidence	
level, 5% precision, and the prevalence of depression among 
TB	patients	 obtained	 in	 a	 previous	 study.[11] The estimated 
sample	size	was	inflated	by	10%	to	adjust	for	nonresponse	to	
arrive at a minimum sample of the patients to participate in this 
study. These subjects were selected using a multistage sampling 
technique. In Stage 1, the three hospitals with the largest 
number	of	patients	in	their	DOTS	clinic	in	Kano	metropolis	
were selected purposively to give a wide representation of 
patients in the environs and those referred from other clinics. 
In Stage 2, a systematic sampling technique was used to select 
patients from each of the three hospitals. The average monthly 
attendance	at	the	DOTS	clinic	of	AKTH,	MMSH,	and	IDH	was	





day in each of the institutions was selected by simple random 
sampling, and every subsequent nth patient selected. Eligible 
patients were recruited until the sample size was achieved.
Study instrument and data collection
Data	were	 collected	 using	 two	 tools:	 both	were	 structured	
and self-administered questionnaires. The first one was 
designed to elicit responses on sociodemographic and 
clinical characteristics of respondents, whereas the second 
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tool was the nine-item tool for screening for depression; 
Patient	Health	Questionnaire	 (PHQ‑9).[12] The tools elicited 
information on the prevalence, pattern, and determinants of 
depression	among	TB	patients.	The	tool	was	also	translated	
into	Hausa	language	and	back‑translated	by	another	person	to	
ensure the accuracy of translation and information obtained. 
Trained	research	assistants	administered	the	“Hausa	version”	
of the questionnaire to non-literate patients. Data were 
analyzed	using 	SPSS	version.	21.0	software	(Armonk,	NY:	
IBM	Corp).	Quantitative	 variables	were	 summarized	using	
mean and standard deviation, whereas qualitative variables 
were summarized using frequencies and percentages. 
Factors associated with depression were determined using 
the	Chi‑square	 test,	 and	predictors	 identified	using	 logistic	
regression analysis. A value of P < 0.05 was considered 
statistically	significant.
Ethical consideration
All participants were given information about the research, its 
objectives	and	potential	benefits.	Respondents	<18	years	signed	
assent forms, caregivers and other adult respondents signed 
consent forms and non-literate respondents appended their 
thumbprints	to	the	forms.	Participation	for	all	was	voluntary	and	
nonparticipation did not affect the care given. They were assured 
of	confidentiality	and	were	free	to	withdraw	from	the	study	at	any	
stage of the questionnaire administration. Ethical clearance was 
obtained	from	the	Research	and	Ethics	Committee	of	AKTH.
Results
Of the 340 questionnaires administered, 325 were completed 
giving a response rate of 95.6%. The age of the respondents 
ranged from 11 to 101 years, with a mean of 40.99 ± 22.06 years. 
Majority were of the Islamic faith (n	 =	 295;	 90.8%),	
were	Hausa	 (n	 =	 245;	 75.4%);	with	more	 than	 half	 being	
males (n	=	192;	59.1%)	and	married	(n	=	179;	55.1%)	[Table 1].
Majority (n	=	278;	85.5%)	of	the	respondents	were	on	treatment	
for	pulmonary	TB	and	a	 few	 for	other	 forms	of	TB	which	
included	TB	spine	(n	=	15;	4.6%),	TB	adenitis	(n	=	20;	6.2%),	
TB	 abdomen	 (n	 =	 7;	 2.2%),	 and	 disseminated	TB	 (n	 =	 3;	
0.9%). Slightly more than half (n	 =	 169;	 52.0%)	were	 in	
the intensive phase of treatment and the others (48%) in the 
continuation phase. About a quarter (n	 =	 76;	 23.4%)	were	
retroviral positive, more than a third (n	=	121;	37.2%)	had	
persistence	of	some	of	the	TB	symptoms,	of	which	majority	
had cough (64.8%) and another third (n	=	105;	32.3%)	had	at	
one	time	or	the	other	experienced	side	effects	of	the	anti‑TB	
medications. About a quarter (n	=	81;	24.9%)	were	on	other	
medications	apart	from	the	anti‑TB	drugs.	Of	those	taking	other	
drugs, most of them were on anti-retroviral drugs (48.1%), 
17.3% on anti-hypertensive, 6.2% on anti-diabetic, and 
9.9% on contraceptive agents. The social habits of the 




as a comorbidity [Figure 1].	Of	these,	the	PHQ‑9	score	ranged	
from 5 to 19, and majority (n	=	120;	75.9%)	had	the	mild	form,	
few (n	=	6;	3.8%)	had	the	moderately	severe	form,	and	none	
had severe depression [Table 3].
Factors associated with depression
At	bivariate	level,	depression	was	significantly	associated	with	
Table 1: Sociodemographic characteristics of respondents

















































Nigerian Journal of Medicine ¦ Volume 29 ¦ Issue 3 ¦ July-September 2020 371
Amole, et al.: Determinants of depression among patients with tuberculosis in urban Kano, North West Nigeria
older	age	(≥60	years)	(Chi‑square	test	[χ2	]	=	18.4; P =	0.001);	
being	widowed	or	divorced	(χ2	=	15.7; P =	0.0001);	having	
primary	or	 informal	 education	 (χ2	 =	 16.3; P =	0.003);	 and	
smoking	cigarette	(χ2	=	6.5; P =	0.01)	[Table 4]. Respondents’ 
clinical	characteristics	associated	with	depression	 included:	
having	 extrapulmonary	TB	 (χ2	 =	 8.34; P =	 0.004);	 being	
HIV	positive	 (χ2	 =	 27.6; P =	 0.0001);	 having	 persistence	
of	TB	 symptoms	 (χ2	 =	 28.3; P =	 0.0001);	 experiencing	
side	 effects	 of	 anti‑TB	 drugs	 (χ2	 =	 6.8; P =	 0.009);	 and	
taking	 other	medications	 aside	 anti‑TB	 drugs	 (χ2	 =	 18.2; 
P =	0.0001)	[Table 5]. After adjusting for potential confounders, 
respondents < 30 years were 67% less likely (adjusted odds 
ratio	[aOR]	=	0.33,	95%	confidence	interval	[CI]	[0.04–0.89])	
to be depressed. Respondents who smoked had more than 
threefold	 (aOR	=	 3.49,	 95%	CI	 [1.22–9.81])	 the	 odds	 of	
being depressed. Clinical characteristics were also associated 
with	depression.	Those	who	were	HIV	negative	were	66%	
less	likely	(aOR	=	0.34,	95%	CI	[0.15–0.64])	to	experience	
depression while those who had the presence of side effects 
of	 anti‑TB	drugs	 and	 the	 persistence	 of	TB	 symptoms	had	
more	 than	 two‑fold	(aOR	=	2.11,	95%	CI	[1.46–5.99])	and	
three‑fold	(aOR	=	3.58,	95%	CI	[1.92–6.90])	the	odds	of	being	
depressed, respectively [Table 6].
dIscussIon
This study observed a high prevalence of comorbidity among 
the	TB	patients	as	one	in	two	of	them	had	depression.	While	the	
majority had the mild form, which may resolve spontaneously 
and not require management with anti-depressants, a few 
with moderate and moderately severe depression would 
require medication (11.6%, n	=	38	patients).	The	predictors	of	
depression among the patients included sociodemographic (age, 
cigarette	 smoking)	 and	 clinical	 characteristics	 (being	HIV	
positive,	experiencing	persistence	of	TB	symptoms	and	side	
effects	of	anti‑TB	drugs).
The additional burden of depression superimposed on 
chronic	diseases	 such	as	TB	may	 interfere	with	 the	quality	
of life of such patients. Failure to take medication during 
TB	 treatment	 is	 a	 known	 cause	 of	 treatment	 failure	 and	
subsequent	 development	 of	MDR‑TB,	which	 is	 difficult	 to	
treat and often associated with more depression.[6,13,14] This may 
create a vicious cycle of increasing prevalence and severity 
of depression if not properly addressed. The patients with 
moderate and moderately severe depression would require a 
holistic approach to management as prognosis in them may 
be poorer if depression remains undiagnosed and untreated. 
The additional burden of depression can also militate against 
adherence, limit the chances of curability, and increase the 
probability	of	progression	to	MDR‑TB.
At bivariate analysis, this study noted factors that affect social 
interactions such as old age, being widowed or divorced, low 
Table 3: Pattern of depression among the respondents
Depression status PHQ‑9 score Frequency (n=158), n (%)
Mild depression 5-9 120 (75.9)




Severe depression 20-27 0 (0.0)
PHQ:	Patient	Health	Questionnaire
Table 2: Clinical characteristics of respondents


























New case 272 (83.7)
Return after default 31 (9.5)




48.6% (n=158)Not depressed,51.4% (n=167)
Figure 1: Prevalence of depression among respondents
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of	 side	 effects	 of	 anti‑TB	 drugs,	 and	 taking	medications	
for	 other	medical	 conditions	were	 significantly	 associated	
with	 depression	 among	 the	TB	patients.	Of	 the	 predictors	
of depression, interestingly, younger respondents were 
somewhat protected against depression. These young people 
are characteristically vibrant, energetic, and full of life. The 
array of interesting activities that they engage in may offer 
some immediate fun and hope for the future. Some attributes 
of increasing age such as decreased quality of life from 
loneliness, unemployment, poverty, presence of comorbidities, 
and the overall decline in body functions were noted in similar 
studies	conducted	in	Nigerian	University	Teaching	Hospitals	
of Ibadan,[8] Ilorin[11] and Enugu;[15] and linked to depression. 
Similar	findings	were	earlier	documented	in	Greece,[16] India[14] 
and in South Africa[17] to contribute to depression.
This study noted smoking as a predictor of depression. 
However,	the	study	did	not	describe	the	temporal	sequence	of	
depression and cigarette smoking, as smoking is considered 
Table 4: Characteristics associated with depression status of respondents
Characteristic No depression Depressed χ2 P
Age group (years)
<30 73 (59.3) 50 (40.7) 18.4 0.001
30-39 30 (56.6) 23 (43.4)
40-49 32 (58.2) 23 (41.8)
50-59 11 (47.8) 12 (52.2)
≥60 21 (29.6) 50 (70.4)
Gender
Male 106 (55.2) 86 (44.8) 2.8 0.10
Female 61 (45.9) 72 (54.1)
Ethnicity
Hausa/Fulani 146 (53.3) 128 (46.7) 2.5 0.11
Others 21 (41.2) 30 (58.8)
Religion
Islam 156 (52.9) 139 (47.1) 2.9 0.09
Christianity 11 (36.7) 19 (63.3)
Marital status
Married 101 (56.4) 78 (43.6) 15.7 0.0001
Single 54 (55.1) 44 (44.9)
Widowed/divorced 12 (25.0) 36 (75.0)
Educational	qualification
None 9 (47.4) 10 (52.6) 16.3 0.003
Qur’anic 39 (41.1) 56 (58.9)
Primary 20 (37.7) 33 (62.3)
Secondary 73 (61.9) 45 (38.1)
Tertiary 26 (65.0) 14 (35.0)
Occupation
Employed 96 (51.6) 92 (48.4) 0.02 0.89
Unemployed 71 (57.8) 66 (42.2)
Income
No Income 46 (46.0) 54 (54.0) 5.7 0.46
<10,000 50 (56.2) 39 (43.8)
10,001-20,000 28 (58.3) 20 (41.7)
20,001-30,000 17 (44.7) 21 (55.3)
30,001-40,000 5 (35.7) 9 (64.3)
40,001-50,000 11 (57.9) 8 (42.1)
Above 50,000 10 (58.8) 7 (41.2)
Cigarette smoking
Yes 10 (30.3) 23 (69.7) 6.5 0.01
No 157 (53.8) 135 (46.2)
Alcohol consumption
Yes 3 (27.3) 8 (72.7) 2.7 0.10
No 164 (52.2) 150 (47.8)
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an adaptive mechanism by many depressed individuals.[18,19] 
Smoking	as	a	risk	factor	for	TB	has	been	documented	among	
patients with mental disorders such as depression.[7]
Clinical characteristics of patients that were related to the 
disease	TB	 and/or	medications	 as	well	 as	 other	medical	
conditions	such	as	HIV,	also	predicted	the	depression	status	
of	 the	 respondents.	Those	 that	 had	TB/HIV	 co‑infection	
were	 significantly	more	depressed	 than	 their	HIV	negative	
counterparts.	This	may	 be	 attributed	 to	 the	 fact	 that	HIV	
infection alone carries a huge emotional and clinical burden, let 
alone when it coexists with another chronic infection such as 
TB.	This	result	is	similar	to	what	was	noted	in	South	Africa[17] 
and in Ethiopia.[20]
Respondents	with	 persistent	TB	 symptoms	 (cough,	 night	
sweat, fever, neck swelling, lower limb weakness, etc.) 
were	significantly	more	depressed	when	compared	to	those	
who	were	free	of	TB	symptoms.	In	general,	the	persistence	
of symptoms may suggest to patients that they are not 
getting cured, are getting worse or failing treatment. The 
stigmatization that follows the persistence of such symptoms 
may also worsen a depressive state. This persistence of 
symptoms being associated with a depressive state was also 
reported from India[14] and Ilorin, Nigeria.[12] Respondents 
that	 had	 experienced	 side	 effects	 from	 their	 anti‑TB	
medications	were	significantly	more	depressed	than	those	
who did not. The presence of side effects from medications 
may likely increase the clinical and emotional burden on 
the already existing disease state and further precipitate 
depression episodes.
This study compares with other studies. The observed 
prevalence (48.6%) is higher than what was reported in 
different	parts	of	Nigeria:	Ibadan	(45.5%),[8] Enugu (41.9%),[15] 
and	Kwara	(27.7%).[11] It is, however, comparable to what was 
reported	in	Greece	(49.2%)[16] in a study among patients with 
TB	and	other	chronic	pulmonary	diseases	such	as	asthma	and	
chronic obstructive pulmonary disease. While the prevalence 
reported by a study conducted in Romania (38.98%) 
was lower than what this study noted,[21] others reported 
prevalence that was slightly higher in Ethiopia (51.9%),[5] 
and	much	 higher	 proportions	 in	 Pakistan	 (80%).[10] The 
pattern of depression found in this study is similar to what 
was	reported	in	the	University	of	Ilorin	Teaching	Hospital,	
in which the majority (77.8%) had mild form, and none 
had a severe form.[11] Studies in Ethiopia, however, showed 
a much lower proportion of the patients studied had mild 
depression (34.2%),[5] and (37.1%).[20] Other studies reported 
the	 significant	 contributions	 of	 factors	 such	 as	 gender,[8,16] 
education,[13,17] occupation,[13,15] and marital status[4,15,17] on 
depression.
This	 study	 is	 limited	 as	 the	 cultural	 influences	 and	beliefs	
may	have	influenced	the	responses	of	the	participants	hence	
preventing them from giving candid responses; for example, 
some respondents might have concealed their depression 
symptoms due to religious beliefs. Future studies need to 
follow-up and explore management options with changing 
mental	states	of	the	patients.	Health‑care	givers	and	managers	
would need to use innovative approaches to screen and 
monitor closely patients with social factors or other clinical 
characteristics that can precipitate or potentiate depression 
and	 approach	management	 holistically.	 Patients	with	TB	
who have a greater risk of developing depression (old age, 
HIV	co‑infected,	with	 the	 persistence	 of	TB	 symptoms	or	
side effects of medications and cigarette smokers) should 
be screened routinely for depression and referred for further 
evaluation if there is a need.
Table 5: Clinical characteristics associated with depression status of respondents
Characteristic No depression Depressed χ2 P
TB	type
Pulmonary 152 (54.7) 126 (45.3) 8.3 0.004
Extra-pulmonary 15 (31.9) 32 (68.1)
Treatment phase
Intensive 88 (52.1) 81 (47.9) 0.07 0.80
Continuation 79 (50.6) 77 (49.4)
HIV	status
Positive 19 (25.0) 57 (75.0) 27.6 0.0001
Negative 148 (59.4) 101 (40.6)
Persistence	of	TB	symptoms
Yes 39 (32.2) 82 (67.8) 28.3 0.0001
No 128 (62.7) 76 (37.3)
Presence	of	side	effects	of	anti‑TB	drugs
Yes 43 (41.0) 62 (59.0) 6.8 0.009
No 124 (56.4) 96 (43.6)
Intake of other medications
Yes 25 (30.9) 56 (69.1) 18.2 0.0001
No 142 (58.2) 102 (41.8)
TB:	Tuberculosis
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conclusIon
Depression	as	a	comorbidity	is	prevalent	among	TB	patients.	
This study highlights the importance of screening ‘at risk’ 
TB	patients	for	depression.	This	will	positively	enhance		case	
management and prevent complications.
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Table 6: Logistic regression model for predictors of depression among respondents
Characteristic Crude OR (95% CI) Adjusted OR (95% CI) P
Age group (years)
<30 0.29 (0.15-0.54) 0.33 (0.14-0.85) 0.03
30-39 0.32 (0.15-0.68) 0.50 (0.12-2.06) 0.09
40-49 0.30 (0.14-0.63) 0.41 (0.10-1.75) 0.23




Quranic 1.29 (0.48-3.47) 1.75 (0.35-3.89) 0.75
Primary 1.49 (0.52-4.28) 1.36 (0.57-6.35) 0.59
Secondary 0.55 (0.21-1.47) 0.99 (0.15-2.10) 0.30
Tertiary 0.48 (0.16-1.47) 0.45 (0.39-1.79) 0.18
Marital status
Married 0.26 (0.13-0.53) 0.39 (0.21-1.29) 0.13




Negative 0.23 (0.13-0.41) 0.34 (0.15-0.64) 0.001
TB	type
Pulmonary 0.39 (0.20-0.75) 0.66 (0.29-1.53) 0.48
Extrapulmonary Referent
Persistence	of	TB	symptoms
Yes 3.54 (2.20-5.70) 3.58 (1.92-6.90) 0.0001
No Referent
Presence	of	side	effects	of	anti‑TB	drugs
Yes 1.86 (1.16-2.98) 2.11 (1.46-5.99) 0.001
No Referent
Intake of other medications
Yes 3.12 (1.83-5.33) 0.81 (0.39-2.01) 0.70
No Referent
Cigarette smoking
Yes 2.67 (1.23-5.82) 3.49 (1.22-9.81) 0.03
No Referent
TB:	Tuberculosis,	CI:	Confidence	interval,	OR:	Odds	ratio
www.who.int/news-room/fact-sheets/detail/tuberculosis. [Last accessed 
on 2020 Jan 04].
3.	 World	Health	Organization.	TB	Comorbidities	and	Risk	Factors;	2019.	
Available	 from:	 https://www.who.int/tb/areas‑of‑work/treatment/risk‑




5.	 Dasa	TT,	Roba	AA,	Weldegebreal	F,	Mesfin	F,	Asfaw	A,	Mitiku	H,	et al. 
Prevalence	 and	 associated	 factors	 of	 depression	 among	 tuberculosis	
patients	in	Eastern	Ethiopia.	BMC	Psychiatry	2019;19:82.
6.	 Jawad	 K,	 Mehreen	 S,	 Haq	 ZU,	 Amin	 M,	 Iqbal	 Z,	 Yousaf	 M.	 The	
frequency of depression in the treatment of multi drug resistant 
tuberculosis.	Pak	J	Chest	Med	2017;23:134‑8.
7.	 World	Health	Organization.	Tuberculosis.	2017.	Available	from:	https://
www.who.int/tb/features_archive/whd2017_TB/en/.	 [Last	 accessed	 on	
2019 Sep 13].
8.	 Ige	 OM,	 Lasebikan	 VO.	 Prevalence	 of	 depression	 in	 tuberculosis	
patients in comparison with non-tuberculosis family contacts visiting 




Nigerian Journal of Medicine ¦ Volume 29 ¦ Issue 3 ¦ July-September 2020 375
Amole, et al.: Determinants of depression among patients with tuberculosis in urban Kano, North West Nigeria
Indian	J	Public	Health	2019;63:39‑43.
10.	 Sulehri	MA,	Dogar	 IA,	 Sohail	H,	Mehdi	Z,	Azam	M,	Niaz	O,	 et al. 
Prevalence	 of	 depression	 among	 tuberculosis	 patients.	 APMC	
2010;4:133‑7.
11.	 Issa	 BA,	 Yussuf	 AD,	 Kuranga	 SI.	 Depression	 comorbidity	 among	









15.	 Aniebue	 PN,	 Okonkwo	 KO.	 Prevalence	 of	 depressive	 symptoms	
amongst	TB	patients	at	University	of	Nigeria	Teaching	Hospital,	Enugu.	
J	Coll	Med	2006;11:120‑4.
16.	 Moussas	 G,	 Tselebis	 A,	 Karkanis	 A,	 Stamouli	 D,	 Ilias	 I,	 Bratis	 D,	






18. Michael W, Rebecca C. Smoking and depression perpetuate one another. 
J	Consult	Clin	Psychol	2001;32:464.




et al.	 Common	 mental	 disorders	 in	 TB/HIV	 co‑infected	 patients	 in	
Ethiopia.	BMC	Infect	Dis	2010;10:201.
21.	 Adina	 MM,	 Necrelescu	 OL,	 Bondor	 C,	 Tronfor	 A,	 Alexandrescu	
D, Dentes E. Depressive syndrome, anxiety and illness perception 
in tuberculosis patients. Recent Res Modern Med 2010. Available 
from:	 http://www.wseas.us/e‑library/conferences/2011/Cambridge/
MEDICAL/MEDICAL-28.pdf. [Last accessed on 2019 Dec 02].
Nigerian Journal of Medicine ¦ Volume 29 ¦ Issue 3 ¦ July-September 2020376
